Top Buy
| Wertpapier | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 1 | 0 | 8,23 € | 27,83 € | 238,08 % |
| Natural Alternat. | 19 | 1 | 2 | 0 | 5,65 € | - | - |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | 78,30 € | 102,62 € | 31,06 % |
| G1 Therapeutics | 21 | 2 | 7 | 1 | 2,39 € | 10,54 € | 341,15 % |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | 2,94 € | 11,04 € | 275,59 % |
| United Therapeutics | 21 | 0 | 3 | 0 | 287,30 € | 288,66 € | 0,47 % |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | 7,49 € | 26,24 € | 250,28 % |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | 15,63 € | 28,06 € | 79,60 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | 34,80 € | 85,51 € | 145,72 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 157,00 € | 200,06 € | 27,43 % |
| AbbVie Inc. | 23 | 0 | 2 | 0 | 159,98 € | 175,11 € | 9,46 % |
| Amgen Inc. | 26 | 0 | 1 | 0 | 285,45 € | 298,90 € | 4,71 % |
| Intra-Cellular Therapies Inc. | 28 | 0 | 4 | 0 | 69,50 € | 79,68 € | 14,65 % |
| Pfizer Inc. | 29 | 4 | 2 | 0 | 25,50 € | 41,10 € | 61,19 % |
| Insmed Inc. | 30 | 1 | 12 | 1 | 60,50 € | 63,62 € | 5,16 % |
| Merck & Co. Inc. | 31 | 1 | 3 | 0 | 119,40 € | 124,97 € | 4,67 % |
| Neurocrine Bioscience | 32 | 0 | 3 | 0 | 121,40 € | 140,87 € | 16,04 % |
| Cytokinetics Inc. | 33 | 1 | 7 | 0 | 48,40 € | 83,56 € | 72,65 % |
| Johnson & Johnson | 34 | 1 | 3 | 0 | 135,54 € | 187,15 € | 38,08 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 142,15 € | 236,30 € | 66,23 % |
| Regeneron Pharmaceuticals Inc. | 39 | 1 | 3 | 0 | 968,20 € | 1.006,8 € | 3,99 % |
| Vertex Pharmaceuticals Inc. | 49 | 2 | 5 | 0 | 433,55 € | 428,60 € | -1,14 % |
| Biogen Inc. | 50 | 1 | 4 | 0 | 208,90 € | 293,22 € | 40,37 % |
| Eli Lilly Corp. | 54 | 0 | 6 | 0 | 833,50 € | 800,00 € | -4,02 % |